Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)

Bookmark and Share
Published: 31 May 2020
Views: 2265
Dr Dimpy Shah - Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA

Dr Dimpy Shah speaks to ecancer about data into the clinical impact of COVID-19 on patients with cancer from the COVID-19 and Cancer Consortium (CCC19), presented at the 2020 ASCO virtual meeting.

She explains that CCC19 has over 100 cancer centres and institutions participating and is the largest registry collecting data on COVID-19 and cancer patients with a global reach.

Dr Shah reports that, looking at the data from over 1000 cases, one of the main findings showed the overall mortality rate for cancer patients with COVID-19 to be 13%, which is more than double the global reported death rate.

She also details some of the risk factors associated with increased risk of mortality: older age, male sex, former smoker and having two or more comorbidities or chronic conditions.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Read more about the study here.